Pharsight

Drugs that contain Buprenorphine Hydrochloride

1. Belbuca patents expiration

Can you believe BELBUCA received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8147866 BDSI Transmucosal delivery devices with enhanced uptake
Jul, 2027

(3 years from now)

US9655843 BDSI Transmucosal delivery devices with enhanced uptake
Jul, 2027

(3 years from now)

US9901539 BDSI Transmucosal drug delivery devices for use in chronic pain relief
Dec, 2032

(8 years from now)

Market Authorisation Date: 23 October, 2015

Treatment: Treatement of pain by transmucosal delivery of buprenorphine; Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment option...

Dosage: FILM;BUCCAL

How can I launch a generic of BELBUCA before it's drug patent expiration?
More Information on Dosage

BELBUCA family patents

Family Patents

2. Probuphine patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7736665 TITAN PHARMS Implantable polymeric device for sustained release of buprenorphine
Apr, 2024

(a month from now)

Market Authorisation Date: 26 May, 2016

Treatment: For opioid dependence

Dosage: IMPLANT;IMPLANTATION

More Information on Dosage

PROBUPHINE family patents

Family Patents